Abstract
Astragalus extract mixture HT042 is a standardized functional food granted by the Korean FDA for promoting “Children’s Height Growth”. In this study, we determined whether HT042 affects circulatory Insulin-like growth factor-1 (IGF-1) after administration and investigated whether Growth hormone (GH), Growth hormone-releasing hormone receptor (GHRH-R), and Growth hormone secretagogue receptor (GHS-R) mRNAs are expressed in the pituitary, and whether Growth hormone-releasing hormone (GHRH) and Somatostatin (SST) are expressed in the hypothalamus. We also evaluated the growth effect of HT042 on endochondral bone formation. Male Sprague-Dawley rats in the control and HT042 groups were orally administered a single dose of the control and HT042, respectively, and those in the recombinant human GH (rhGH) group were subcutaneously injected with rhGH. Tetracycline was injected intraperitoneally 72 h prior to sacrifice to decide endochondral bone formation. To determine the endocrine or paracrine/autocrine mechanism, we evaluated the expression of local BMP-2 and IGF-1, an immunohistochemical study after HT042 administration. It was confirmed that the growth-promoting effect of HT042 can be contributed to the increase in serum IGF-1, which can be stimulated by GH secretion. Administration of HT042 modulated the activity of GHRH-R and GHR-S in the pituitary gland and promoted GH secretion, thereby changing longitudinal growth through GH/IGF-1 mediation. Results for GHRH and SST expression demonstrated that the hypothalamus can be influenced and mediated by HT042 through a complex neuroendocrine regulatory system. In addition, it was confirmed by oral administration for 10 days that HT042 increased bone formation in cartilage, which is important for height growth. The effect of HT042 could be owing to upregulation of local Bone morphogenetic protein-2 (BMP-2) and IGF-1 expression in the growth plate, which could be regarded as a GH-dependent autocrine/paracrine pathway, as well as circulatory IGF-1.
Highlights
IntroductionGrowth and development are achieved by adequate nutritional supply externally and by a combination of hormones internally, and if any of these external and internal mechanisms of action are functioning abnormally, normal growth cannot be expected [1]
Licensee MDPI, Basel, Switzerland.Growth and development are achieved by adequate nutritional supply externally and by a combination of hormones internally, and if any of these external and internal mechanisms of action are functioning abnormally, normal growth cannot be expected [1].Long bone growth is a consequence of endochondral ossification process in which cartilage changes to bone, mainly controlled by growth hormone (GH) and insulin-like growth factor-1 (IGF-1) [2]
It is suggested that the growth-stimulating effect of HT042 may be due to the increase in serum IGF-1, which can be stimulated by GH secretion
Summary
Growth and development are achieved by adequate nutritional supply externally and by a combination of hormones internally, and if any of these external and internal mechanisms of action are functioning abnormally, normal growth cannot be expected [1]. Long bone growth is a consequence of endochondral ossification process in which cartilage changes to bone, mainly controlled by growth hormone (GH) and insulin-like growth factor-1 (IGF-1) [2]. GH plays a chief role in postnatal growth, which is secreted. In a pulsating manner in the anterior pituitary gland [3]. This pulsatile secretion plays an important part in metabolic action, which is induced by growth hormone-releasing hormone (GHRH) and is inhibited by somatostatin (SST) [4]. GH regulates growth either directly through receptors or indirectly by inducing liver or local production through IGH-1 [5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
